Cekelan dhuwit saben saham Sanofi Group (SNY)

Sanofi - logo grafis emiten SNY

Sanofi (SNY) demonstrates the resilience of the defensive sector by focusing on immunological innovations. The company is implementing AI and automation to accelerate drug releases. Costly cold chain logistics ensure the integrity of complex vaccines. The amount of cash per share helps assess the intrinsic value of the stock, and 3.06 captures the magnitude of this parameter on this chart.

SNY (Sanofi Aventis) riwayat Dhuwit awis saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Sanofi

- rega saiki lan proyeksi nilai saham:
- rincian kapitalisasi pasar:
- indikator anane dhuwit lan arus kas:
Analisis umum perusahaan:SNY (Sanofi Group)
Produk asil prodhuksi Sanofi SA

This indicator calculates the volume of liquid assets per share, allowing for an objective assessment of the business's financial stability and its protection against default. By analyzing the cash per security metric, an investor can see how the ultra-high margins from the sale of patented drugs by Sanofi (SNY) transform into real capital, ensuring a balance between security and growth rates.